Webinar - The role of excipients in determining n-nitrosamine risks for drug products

An IPEC Federation webinar

Who should attend?
> Excipient manufacturers, users, distributors
> Regulatory affairs
> Compendial affairs
> Quality affairs



The webinar will be run twice and will follow the same structure.
The link to connect to the session chosen will be shared shortly before the event starts.

The role of excipients in determining N-nitrosamine risks for drug products


16 and 17 July 2024

Nitrosamines and related compounds continue to be a global concern.

Regulators requested drug product manufacturers to identify products at risk of N-nitrosamine formation or contamination, which could impact the pharmaceutical industry supply chain.

The understanding of nitrosamine formation in drug products continues to evolve. This webinar provides an overview of the role of excipients in drug product risk assessments, including the recently revised IPEC Federation position paper.

In addition, the webinar includes best practice strategies and examples for ongoing communication between excipient suppliers and users. Open communication between drug product manufacturers and excipient suppliers is essential to ensure the appropriate information is obtained to perform risk assessments.



Session 1 – for an audience based in Europe/Americas – Tuesday 16 July – 16:00-17:00 CEST / 10:00-11:00 EDT
Session 2 – for an audience based in Asia/Europe – Wednesday 17 July – 9:00-10:00 CEST / 12:30-13:30 IST / 15:00-16:00 CST / 16:00-17:00 JST

Registration for this webinar is now closed. Please contact info@ipec-federation.org for further information.

For further information, please contact info@ipec-federation.org.

IPEC Federation

IPEC Federation asbl
Rue Marie de Bourgogne 52 – 1000 Brussels – Belgium
T: +32 (0)2 213 74 40 – M: info@ipec-federation.org

VAT: BE0823931361 – RPM Brussels Capital Region
IBAN: BE73363068125160

Privacy policy